Transform product concepts into compliant, scalable innovations through feasibility, prototyping, and regulatory-aligned development.
Innovation to Commercialisation Program supports brands in transforming scientific and technical concepts into compliant, market-ready products. From early-stage feasibility and regulatory risk analysis to development guidance and launch alignment, the program embeds execution foresight into every phase of innovation.
Structured Journey to
ComplianceBuilt to guide every step with clarity, speed, and regulatory precision - from planning to execution.
Analyse target market trends, applicable regulatory classifications, and category-specific challenges.
Evaluate ingredient acceptability, restrictions, and pre-approval status based on regional regulations.
Assess chemical, functional, and regulatory compatibility between components in the intended formulation.
Conduct trials to determine stability, solubility, and potential interactions of selected ingredients.
Establish the complete technical formulation, listing all components with defined specifications.
Prepare small-scale batches to validate formulation performance and process parameters.
Assess key properties such as pH, viscosity, dispersion, and appearance for initial quality benchmarks.
Execute limited-scale production runs to simulate commercial manufacturing conditions and process scalability.
Conduct validated analytical testing and ICH-compliant stability studies to establish product shelf life.
Evaluate the safety and performance profile through clinical data review or documented claims substantiation.
Ensure formulation and process compatibility with identified CDMOs or manufacturing partners.
Assess packaging formats for compatibility, stability, regulatory compliance, and cost efficiency.
Services
Connect with vetted manufacturing partners to scale your formulation into compliant commercial batches
Navigate tech transfer and licensing with regulatory alignment across CDMOs, CMOs, and local partners
Access expert input on formulation, testing protocols, and technical documentation to support smooth scale-up
Assess and qualify manufacturing facilities to ensure regulatory, quality, and capacity readiness.
USP
Flexibility
Pilot-to-Scale Execution
Structured Execution Model
Our Global
PresenceProven Impact.
Precision in ExecutionAccelerated product readiness through compliance-aligned development, technical validation, and seamless transition from lab to launch.
From compliance to commercial success we’ve got you covered.
Questions
Our modular model supports scale - from single product surveillance to portfolio-wide coverage, with options to expand to new geographies.
Yes, we reconcile safety data from multiple sources and consolidate it into regulator-ready PSURs, PBRERs, or PMCFs with narrative support.
We build tailored SOPs, integrate root cause tools (e.g., Ishikawa, 5-Why), and align the process to your product class and geography.
We handle case intake, evaluation, and submissions to systems like MedWatch, EudraVigilance, and PVPI -ensuring format and timeline compliance.
Yes ,our program is structured to support both pharma (AE case management, PBRERs) and devices (PMCF, trend reports) through a unified framework.
Yes ,we assess packaging feasibility for compliance and stability, and we review claims for regulatory alignment and substantiation.
No problem. The program is modular - you can engage for pilot batch execution or any other defined phase independently.
Absolutely. Through our partner lab network, we coordinate analytical, stability, and safety testing as part of the launch preparation process.
Yes, we conduct region-specific ingredient reviews to assess acceptability, regulatory status, and associated risks across target geographies.
This program is designed to support both early-stage concept development and post-formulation refinement. The earlier you engage, the more aligned your product will be with regulatory and market expectations.
Yes - the program is fully modular. You can choose specific steps based on your internal readiness and regulatory needs.
Timelines vary by product type and market, but most projects are completed within 6-9 months, which is 15-20% faster than standard industry timelines.
It’s built for both. Whether you're entering a market for the first time or expanding your footprint, the program adapts to your regulatory maturity and market goals.
Regnova or its channel partners can act as MAH or legal representatives, ensuring full compliance without needing a local entity.
Unlike traditional advisory models, this program offers end-to-end execution -from feasibility assessment to dossier submission and MAH support -with built-in speed and regional alignment.
Avoid costly pivots. Design for compliance. Build boldly. Regnova’s Innovation Commercialization Enablement program keeps your innovation moving at market speed.